Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a

Clinical Immunology

Volumn 148, Issue 1, 2013, Pages 35-43

  Wahid, Rezwanul ^a   Simon, Jakub K ^b   Picking, Wendy L ^c   Kotloff, Karen L ^a   Levine, Myron M ^a   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b NanoBio Corporation   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

B memory; Human challenge; IpaB; LPS; Protection; Shigella

Indexed keywords

LIPOPOLYSACCHARIDE; RECOMBINANT ANTIGEN; RECOMBINANT INVASION PLASMID ANTIGEN B; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE SEVERITY; ESCHERICHIA COLI; HUMAN; HYBRID; IMMUNIZATION; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SHIGELLA FLEXNERI; YERSINIA PESTIS;

EID: 84877316351     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.03.009     Document Type: Article

References (39)

1. von Seidlein L., Kim D.R., Ali M., Lee H., Wang X., Thiem V.D., Canh d.G., Chaicumpa W., Agtini M.D., Hossain A., Bhutta Z.A., Mason C., Sethabutr O., Talukder K., Nair G.B., Deen J.L., Kotloff K., Clemens J. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 2006, 3:e353.
2. Kotloff K.L., Winickoff J.P., Ivanoff B., Clemens J.D., Swerdlow D.L., Sansonetti P.J., Adak G.K., Levine M.M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 1999, 77:651-666.
3. Pickering L.K. Antimicrobial resistance among enteric pathogens. Semin. Pediatr. Infect. Dis. 2004, 15:71-77.
4. Levine M.M., Kotloff K.L., Barry E.M., Pasetti M.F., Sztein M.B. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat. Rev. Microbiol. 2007, 5:540-553.
5. Newland J.W., Hale T.L., Formal S.B. Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen. Vaccine 1992, 10:766-776.
6. Kotloff K.L., Nataro J.P., Losonsky G.A., Wasserman S.S., Hale T.L., Taylor D.N., Sadoff J.C., Levine M.M. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 1995, 13:1488-1494.
7. Kotloff K.L., Losonsky G.A., Nataro J.P., Wasserman S.S., Hale T.L., Taylor D.N., Newland J.W., Sadoff J.C., Formal S.B., Levine M.M. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 1995, 13:495-502.
8. Cohen D., Green M.S., Block C., Slepon R., Ofek I. Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J. Clin. Microbiol. 1991, 29:386-389.
9. DuPont H.L., Hornick R.B., Snyder M.J., Libonati J.P., Formal S.B., Gangarosa E.J. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J. Infect. Dis. 1972, 125:12-16.
10. Ferreccio C., Prado V., Ojeda A., Cayyazo M., Abrego P., Guers L., Levine M.M. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am. J. Epidemiol. 1991, 134:614-627.
11. Kaminski R.W., Oaks E.V. Inactivated and subunit vaccines to prevent shigellosis. Expert Rev. Vaccines 2009, 8:1693-1704.
12. Oaks E.V., Hale T.L., Formal S.B. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect. Immun. 1986, 53:57-63.
13. Oberhelman R.A., Kopecko D.J., Salazar-Lindo E., Gotuzzo E., Buysse J.M., Venkatesan M.M., Yi A., Fernandez-Prada C., Guzman M., Leon-Barua R. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. Infect. Immun. 1991, 59:2341-2350.
14. Islam D., Christensson B. Disease-dependent changes in T-cell populations in patients with shigellosis. APMIS 2000, 108:251-260.
15. Raqib R., Ljungdahl A., Lindberg A.A., Andersson U., Andersson J. Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection. Gut 1996, 38:328-336.
16. Samandari T., Kotloff K.L., Losonsky G.A., Picking W.D., Sansonetti P.J., Levine M.M., Sztein M.B. Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain. J. Immunol. 2000, 164:2221-2232.
17. Crotty S., Ahmed R. Immunological memory in humans. Semin. Immunol. 2004, 16:197-203.
18. Lanzavecchia A., Bernasconi N., Traggiai E., Ruprecht C.R., Corti D., Sallusto F. Understanding and making use of human memory B cells. Immunol. Rev. 2006, 211:303-309.
19. Ramirez K., Wahid R., Richardson C., Bargatze R.F., El-Kamary S.S., Sztein M.B., Pasetti M.F. Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers. Clin. Immunol. 2012, 144:98-108.
20. Simon J.K., Wahid R., Maciel M., Picking W.L., Kotloff K.L., Levine M.M., Sztein M.B. Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates. Vaccine 2009, 27:565-572.
21. Simon J.K., Maciel M., Weld E.D., Wahid R., Pasetti M.F., Picking W.L., Kotloff K.L., Levine M.M., Sztein M.B. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. Clin. Immunol. 2011, 139:185-192.
22. Wahid R., Pasetti M.F., Maciel M., Simon J.K., Tacket C.O., Levine M.M., Sztein M.B. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. Clin. Immunol. 2011, 138:187-200.
23. Wahid R., Simon R., Zafar S.J., Levine M.M., Sztein M.B. Live oral typhoid vaccine Ty21a induces cross reactive humoral immune responses against S. Paratyphi A and S. Paratyphi B in humans. Clin. Vaccine Immunol. 2012, 19:825-834.
24. Westphal O., Jann K., Himmelspach K. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog. Allergy 1983, 33:9-39.
25. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 2004, 286:111-122.
26. Oaks E.V., Turbyfill K.R. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Vaccine 2006, 24:2290-2301.
27. Sani M., Allaoui A., Fusetti F., Oostergetel G.T., Keegstra W., Boekema E.J. Structural organization of the needle complex of the type III secretion apparatus of Shigella flexneri. Micron 2007, 38:291-301.
28. Edwards K.M. Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines. Clin. Infect. Dis. 2001, 33(Suppl. 4):S274-S277.
29. Plotkin S.A., Gilbert P.B. Nomenclature for immune correlates of protection after vaccination. Clin. Infect. Dis. 2012, 54:1615-1617.
30. Harris A.M., Bhuiyan M.S., Chowdhury F., Khan A.I., Hossain A., Kendall E.A., Rahman A., LaRocque R.C., Wrammert J., Ryan E.T., Qadri F., Calderwood S.B., Harris J.B. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 2009, 77:3850-3856.
31. Jayasekera C.R., Harris J.B., Bhuiyan S., Chowdhury F., Khan A.I., Faruque A.S., LaRocque R.C., Ryan E.T., Ahmed R., Qadri F., Calderwood S.B. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 2008, 198:1055-1061.
32. Patel S.M., Rahman M.A., Mohasin M., Riyadh M.A., Leung D.T., Alam M.M., Chowdhury F., Khan A.I., Weil A.A., Aktar A., Nazim M., LaRocque R.C., Ryan E.T., Calderwood S.B., Qadri F., Harris J.B. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin. Vaccine Immunol. 2012, 19:842-848.
33. El-Kamary S.S., Pasetti M.F., Mendelman P.M., Frey S.E., Bernstein D.I., Treanor J.J., Ferreira J., Chen W.H., Sublett R., Richardson C., Bargatze R.F., Sztein M.B., Tacket C.O. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J. Infect. Dis. 2010, 202:1649-1658.
34. Sallusto F., Lanzavecchia A., Araki K., Ahmed R. From vaccines to memory and back. Immunity 2010, 33:451-463.
35. Sundstrom P., Lundin S.B., Nilsson L.A., Quiding-Jarbrink M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur. J. Immunol. 2008, 38:3327-3338.
36. Cam P.D., Pal T., Lindberg A.A. Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients. J. Clin. Microbiol. 1993, 31:454-457.
37. Cohen D., Green M.S., Block C., Rouach T., Ofek I. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J. Infect. Dis. 1988, 157:1068-1071.
38. Cohen D., Green M.S., Block C., Slepon R., Lerman Y. Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide. J. Infect. Dis. 1992, 165:785-787.
39. Hale T.L., Sansonetti P.J., Schad P.A., Austin S., Formal S.B. Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect. Immun. 1983, 40:340-350.